Modern neurogenetic representations of MELAS syndrome. Clinical cases (the lecture)
https://doi.org/10.17650/2073-8803-2019-14-4-26-31
Abstract
This lecture with a description of clinical cases presents information on such a mitochondrial disease from the group of hereditary metabolic diseases, like MELAS syndrome (OMIM: 540000). The main manifestations of this progressive disease are stroke-like episodes and a specific form of encephalopathy, including epileptic seizures with the presence of a phenomenon of "ragged red fibers" and early dementia. Clinical cases, given in this lecture, supplement the piggy bank of genetically verified mitochondrial diseases leading to the development of polymorphic neurological disorders and characteristic neuroimaging picture, namely the appearance of polymorphic ischemic changes in the temporal, parietal or occipital regions of the brain, that do not correspond to the zones of the main vascular blood supply, as the basis for the formation of such focus is the phenomenon of mitochondrial angiopathy, and not thrombosis. The description of clinical cases reflects our own observations and the main steps in the diagnosis of this severe hereditary disease, taking into account of the latest neurogenetic representations. In addition to the data given in the clinical course of the disease, the results of the genetic interpretation of the MELAS syndrome are given; modern methods of diagnosis and therapy are considered.
About the Authors
A. V. ShatalinRussian Federation
61/2 Shchepkina St., Moscow 129110, Russia
E. V. Mukhina
Russian Federation
61/2 Shchepkina St., Moscow 129110, Russia
A. S. Kotov
Russian Federation
61/2 Shchepkina St., Moscow 129110, Russia
M. G. Amirkhanyan
Russian Federation
61/2 Shchepkina St., Moscow 129110, Russia
References
1. Amirkhanyan M.G., Kotov A.S., Eliseev Yu.V., Shatalin A.V. Variants of pathomorphosis of clinical manifestations of focal epilepsy. Russkiy zhurnal detskoy nevrologii = Russian Journal of Child Neurology 2017;12(3):34–43. (In Russ.)
2. Gintera E.K., Puzyreva V.P. Hereditary diseases: a national guideline. A brief edition. Moscow: GEOTAR-Media, 2017. Pp. 184–7. (In Russ.)
3. Zakharova E.Yu., Mikhaylova S.V., Rudenskaya G.E. et al. Differential diagnosis of leukodystrophy. Meditsinskaya genetika = Medical Genetics 2004;(10):453–9. (In Russ.)
4. Illarioshkin S.N., Ivanova-Smolenskaya I.A., Markova E.D. DNA diagnostics and medical genetic counseling in neurology. Moscow: MIA, 2002. 591 p. (In Russ.)
5. Kotov S.V., Stakhovskaya L.V. Stroke: a guideline for physicians. Moscow: MIA, 2009. 400 p. (In Russ.)
6. Mikhaylova S.V., Zakharova E.Yu., Petrukhin A.S. Neurometabolic diseases in children and adolescents: approaches to the diagnosis and treatment. Moscow: Litera, 2015. 352 p. (In Russ.)
7. Sidorova O.P., Neretin V.Ya., Agafonov B.V. Medical and genetic counseling for hereditary and congenital diseases of the nervous system. Moscow: MIA, 2004. 224 p. (In Russ.)
8. Anglin R.E., Garside S.L., Tarnopolsky M.A. et al. The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. J Clin Psychiatry 2012;73(4):506–12. DOI: 10.4088/JCP.11r07237.
9. Koga Y., Povalko N., Nishioka J. et al. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci 2010;1201:104–10. DOI: 10.1111/j.1749-6632.2010.05624.x.
10. Tang S., Wang J., Zhang V.W. et al. Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects. Hum Mutat 2013;34(6):882–93. DOI: 10.1002/humu.22307.
Review
For citations:
Shatalin A.V., Mukhina E.V., Kotov A.S., Amirkhanyan M.G. Modern neurogenetic representations of MELAS syndrome. Clinical cases (the lecture). Russian Journal of Child Neurology. 2019;14(4):26-31. (In Russ.) https://doi.org/10.17650/2073-8803-2019-14-4-26-31